Axxion »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Axxion

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Axxion from 13F filings

Historical chart of Axxion investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Axxion consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Axxion

Quarter filed Position value Share count Share price at filing
2026-09-30 $426k 400k 1.06

More positions owned by Axxion

Carvana Cl A (CVNA)
Meta Platforms Cl A (META)
Credit Acceptance (CACC)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Interactive Brokers Group In Com Cl A (IBKR)
Apple (AAPL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Okta Cl A (OKTA)
Yum China Holdings (YUMC)
Atour Lifestyle Hldgs Sponsored Ads (ATAT)
Eli Lilly & Co. (LLY)
Linde SHS (LIN)
Barrick Mng Corp Com Shs (B)

View all positions for Axxion

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Steelhead Partners
Bnp Paribas Arbitrage, Snc
Alberta Investment Management Corporation
DeepCurrents Investment Group
Bank of America Corporation
FMR
MacKay Shields
Manufacturers Life Insurance Company
Universal- Beteiligungs- und Servicegesellschaft mbH
Bnp Paribas Investment Partners
State Street Corporation
CSS
Ameriprise Financial
BlackRock
Toronto-Dominion Bank

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1